Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Accured Expenses: 2020-2024

Historic Change in Accured Expenses for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to $1.9 million.

  • Core Scientific's Change in Accured Expenses rose 2409.47% to $34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.7 million, marking a year-over-year decrease of 1.13%. This contributed to the annual value of $1.9 million for FY2024, which is 98.56% down from last year.
  • Per Core Scientific's latest filing, its Change in Accured Expenses stood at $1.9 million for FY2024, which was down 98.56% from $130.4 million recorded in FY2023.
  • In the past 5 years, Core Scientific's Change in Accured Expenses ranged from a high of $130.4 million in FY2023 and a low of $1.6 million during FY2020.
  • For the 3-year period, Core Scientific's Change in Accured Expenses averaged around $49.8 million, with its median value being $17.2 million (2022).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 3,358.46% in 2021, then crashed by 98.56% in 2024.
  • Core Scientific's Change in Accured Expenses (Yearly) stood at $1.6 million in 2020, then skyrocketed by 3,358.46% to $56.2 million in 2021, then crashed by 69.34% to $17.2 million in 2022, then surged by 656.76% to $130.4 million in 2023, then crashed by 98.56% to $1.9 million in 2024.